review Open AccessTop 1% cited
Memantine for dementia
Cochrane Database of Systematic Reviews · 2006 · Vol. 3(2) · pp. CD003154–CD003154
Abstract
Memantine has a small beneficial effect at six months in moderate to severe AD. In patients with mild to moderate dementia, the small beneficial effect on cognition was not clinically detectable in those with vascular dementia and was detectable in those with AD. Memantine is well tolerated.
Neurological Disease Mechanisms and TreatmentsDiet and metabolism studiesNeurological Disorders and TreatmentsMemantineDementiaMedicineClinical trialVascular dementiaRandomized controlled trialPlaceboInternal medicineDiseaseAlternative medicine
MeSH terms
Activities of Daily LivingAgedAged, 80 and overAlzheimer DiseaseCognition DisordersDementiaHumansMemantineDementia, VascularRandomized Controlled Trials as TopicExcitatory Amino Acid Antagonists
Citations
1,019
FWCI
51.30
field-weighted impact
References
94
Percentile
100%
vs. same field & year
Citations per year
Cited by
The <i>Movement</i> Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
Movement Disorders · 2011 · 1,142 citations
Vascular Contributions to Cognitive Impairment and Dementia
Stroke · 2011 · 3,674 citations
Alzheimer’s Disease: The Challenge of the Second Century
Science Translational Medicine · 2011 · 1,414 citations
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse
Neuropharmacology · 2007 · 683 citations
Alzheimer's disease: Recent treatment strategies
European Journal of Pharmacology · 2020 · 515 citations
Dementia prevention, intervention, and care
The Lancet · 2017 · 6,106 citations
Therapeutics of Alzheimer's disease: Past, present and future
Neuropharmacology · 2013 · 744 citations
A Meta-Analysis of Cytokines in Alzheimer's Disease
Biological Psychiatry · 2010 · 1,097 citations
References
A new rating scale for Alzheimer's disease
American Journal of Psychiatry · 1984 · 4,157 citations
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
JAMA · 1995 · 5,583 citations
The Neuropsychiatric Inventory
Neurology · 1994 · 7,484 citations
Clinical diagnosis of Alzheimer's disease
Neurology · 1984 · 27,910 citations
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
Neuropharmacology · 1999 · 869 citations
ECDEU Assessment Manual for Psychopharmacology
Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8,823 citations
Empirical Evidence of Bias
JAMA · 1995 · 5,518 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.